A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2004

Study Completion Date

August 31, 2005

Conditions
Cystic Fibrosis
Interventions
DRUG

Inhaled mannitol

Trial Locations (8)

2050

Royal Prince Alfred Hospital, Sydney

2145

Childrens Hospital at Westmead, Sydney

3052

Royal Children's Hospital, Melbourne

3181

The Alfred Hospital, Melbourne

6840

Princess Margaret Hospital for Children, Perth

Unknown

Prince Charles Hospital, Brisbane

Sir Charles Gairdner, Perth

Greenlane Hospital, Auckland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Syntara

INDUSTRY